Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone in Dry Age Related Macular Degeneration
NCT00466076Phase 3Unknown
- Sponsor
- Kaplan Medical Center
- Start
- Aug 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glatiramer acetate in age-related macular degeneration (AMD), sponsored by Kaplan Medical Center. Status: unknown.
02
Drugs
glatiramer acetate
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00466076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466076.